Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,958 | -38,327 | 168,024 | 205,667 | 241,198 |
| Depreciation Amortization | 1,743 | 881 | 3,924 | 3,028 | 2,062 |
| Accounts receivable | 3,940 | -4,282 | 93,557 | 101,895 | 106,161 |
| Accounts payable and accrued liabilities | 4,253 | 2,564 | -19,556 | -14,468 | 833 |
| Other Working Capital | -56,398 | -23,681 | -5,842 | -22,182 | -12,793 |
| Other Operating Activity | -14,556 | 4,959 | -378,620 | -392,737 | -409,919 |
| Operating Cash Flow | $-119,976 | $-57,886 | $-138,513 | $-118,797 | $-72,458 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -20,285 | -6,388 | -103,838 | -89,576 | -20,726 |
| Sale Of Investment | 81,671 | 38,135 | 21,462 | 1,650 | 0 |
| Other Investing Activity | -1,100 | -1,092 | 457,463 | 465,851 | 465,878 |
| Investing Cash Flow | $60,286 | $30,655 | $375,087 | $377,925 | $445,152 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -121 | N/A | -233,185 | -233,185 | -233,185 |
| Common Stock Issued | 53,650 | 53,650 | 7,894 | N/A | N/A |
| Common Stock Repurchased | 202 | N/A | 353 | 188 | 188 |
| Other Financing Activity | 3 | -60 | -48,767 | -48,789 | -48,791 |
| Financing Cash Flow | $53,734 | $53,590 | $-273,705 | $-281,786 | $-281,788 |
| Beginning Cash Position | 89,119 | 89,119 | 126,250 | 126,250 | 126,250 |
| End Cash Position | 83,163 | 115,478 | 89,119 | 103,592 | 217,156 |
| Net Cash Flow | $-5,956 | $26,359 | $-37,131 | $-22,658 | $90,906 |
| Free Cash Flow | |||||
| Operating Cash Flow | -119,976 | -57,886 | -138,513 | -118,797 | -72,458 |
| Free Cash Flow | -119,976 | -57,886 | -138,513 | -118,797 | -72,458 |